Literature DB >> 26589469

Protective effects of udenafil citrate, piracetam and dexmedetomidine treatment on testicular torsion/detorsion-induced ischaemia/reperfusion injury in rats.

D Tuglu1, E Yuvanc1, T Ozan2, F Bal1, E Yilmaz1, P Atasoy3, U Kisa4, E Batislam1.   

Abstract

The aim of this study was to investigate the antioxidant properties of udenafil citrate (1.4 mg kg(-1) -2.8 mg kg(-1) ), dexmedetomidine 25 μg kg(-1) and piracetam 200 mg kg(-1) administered on ipsilateral/contralateral testes after ischaemia in a rat model of testicular torsion/detorsion (T/D) and define its protective effect histologically. Fifty-six Wistar albino rats were included and randomly assigned into 6 groups. No intervention was performed in control group (Group 1, n = 8) and in torsion/detorsion group, (Group 2, n = 8). Udenafil 1.4 mg kg(-1) was given to torsion/detorsion group (Group 3, n = 10), udenafil 2.8 mg kg(-1) was given to torsion/detorsion group (Group 4, n = 10), piracetam 200 mg kg(-1) was given to torsion/detorsion group (Group 5, n = 10) and dexmedetomidine 25 μg kg(-1) was given to torsion/detorsion group (Group 6, n = 10) intraperitoneally after 60 mins of testicular torsion. Biochemical and histopathological testicular injury were evaluated. When the tissue was examined by TOS values, Group 3, Group 4 and Group 5 were significantly lower than Group 2. In contrary Group 6 values were significantly higher than Group 2. The increasing doses of udenafil demonstrated antioxidant properties on the testis tissue and histopathological that protects the testicles.
© 2015 Blackwell Verlag GmbH.

Entities:  

Keywords:  Dexmedetomidine; piracetam; total antioxidant capacity (TAC); total oxidant status (TOS); udenafil

Mesh:

Substances:

Year:  2015        PMID: 26589469     DOI: 10.1111/and.12499

Source DB:  PubMed          Journal:  Andrologia        ISSN: 0303-4569            Impact factor:   2.775


  5 in total

1.  Medical perspective in testicular ischemia-reperfusion injury.

Authors:  Salvatore Arena; Roberta Iacona; Pietro Antonuccio; Tiziana Russo; Vincenzo Salvo; Eloisa Gitto; Pietro Impellizzeri; Carmelo Romeo
Journal:  Exp Ther Med       Date:  2017-03-30       Impact factor: 2.447

2.  Protective Effect of Udenafil Against Ischemia Reperfusion Injury Due to Testicular Torsion/Detorsion in Rat Model.

Authors:  Zulfu Sertkaya; Orhan Koca; Metin Ozturk; Mehmet Akyuz; Gulistan Gumrukcu; Musab Ali Kutluhan; Muhammet Ihsan Karaman
Journal:  Eurasian J Med       Date:  2020-06-04

3.  MiR-29a Suppresses Spermatogenic Cell Apoptosis in Testicular Ischemia-Reperfusion Injury by Targeting TRPV4 Channels.

Authors:  Jin-Zhuo Ning; Wei Li; Fan Cheng; Wei-Min Yu; Ting Rao; Yuan Ruan; Run Yuan; Xiao-Bin Zhang; Dong Zhuo; Yang Du; Cheng-Cheng Xiao
Journal:  Front Physiol       Date:  2017-11-29       Impact factor: 4.566

Review 4.  Antioxidants in experimental ischemia-reperfusion injury of the testis: Where are we heading towards?

Authors:  George Vaos; Nick Zavras
Journal:  World J Methodol       Date:  2017-06-26

5.  Administration of Dexmedetomidine Does Not Produce Long-Term Protective Effect on Testicular Damage Post Testicular Ischemia-Reperfusion Injury.

Authors:  Jing Xiao; Wenbo Wan; Ying Zhang; Jun Ma; Lin Yan; Yukun Luo; Jie Tang
Journal:  Drug Des Devel Ther       Date:  2021-01-27       Impact factor: 4.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.